Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Airway Obstruction D000402 13 associated lipids
Uremia D014511 33 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Graft Occlusion, Vascular D006083 11 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Adenocarcinoma D000230 166 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Schelzig H et al. Role of recombinant hirudin in a pig-to-human lung transplantation model. 2002 Transplant. Proc. pmid:12270449
Huang CG et al. Effect of berberine on arachidonic acid metabolism in rabbit platelets and endothelial cells. 2002 Thromb. Res. pmid:12297129
Venuto R et al. Enhanced vascular effects of the Ca(2+) channel agonist Bay K 8644 in pregnant rabbits. 2002 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:11893597
Wainwright CL et al. NCX4016 (NO-aspirin) reduces infarct size and suppresses arrhythmias following myocardial ischaemia/reperfusion in pigs. 2002 Br. J. Pharmacol. pmid:11959790
Sheu JR et al. Mechanisms involved in the antiplatelet activity of midazolam in human platelets. 2002 Anesthesiology pmid:11873041
Horiguchi T et al. Study on the usefulness of seratrodast in the treatment of chronic pulmonary emphysema. 2002 Arzneimittelforschung pmid:12442639
Leahy KM et al. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. 2002 Cancer Res. pmid:11830509
Ma LP et al. Inhibition of platelet aggregation and expression of alpha granule membrane protein 140 and thromboxane B2 with pravastatin therapy for hypercholesterolemia. 2002 J Assoc Acad Minor Phys pmid:11852667
Ochi T and Goto T Differential effect of FR122047, a selective cyclo-oxygenase-1 inhibitor, in rat chronic models of arthritis. 2002 Br. J. Pharmacol. pmid:11834626
Gordon SM et al. Peripheral prostanoid levels and nonsteroidal anti-inflammatory drug analgesia: replicate clinical trials in a tissue injury model. 2002 Clin. Pharmacol. Ther. pmid:12189364
Van Hecken A et al. Effects of enteric-coated, low-dose aspirin on parameters of platelet function. 2002 Aliment. Pharmacol. Ther. pmid:12197849
Gómez-Gaviro MV et al. Structure-function relationship and role of tumor necrosis factor-alpha-converting enzyme in the down-regulation of L-selectin by non-steroidal anti-inflammatory drugs. 2002 J. Biol. Chem. pmid:12147693
Khan AA et al. In vivo selectivity of a selective cyclooxygenase 2 inhibitor in the oral surgery model. 2002 Clin. Pharmacol. Ther. pmid:12152003
Kirchheiner J et al. Enantiospecific effects of cytochrome P450 2C9 amino acid variants on ibuprofen pharmacokinetics and on the inhibition of cyclooxygenases 1 and 2. 2002 Clin. Pharmacol. Ther. pmid:12152005
Wang L et al. Enhancement of human platelet activation by the combination of low concentrations of collagen and rabbit anticardiolipin antibodies. 2002 Br. J. Haematol. pmid:12199800
Jung K et al. The effect of dietary intervention through the modification of fatty acids composition and antioxidant vitamin intake on plasma TXB(2) level in Korean postmenopausal women with hypercholesterolemia. 2002 J. Korean Med. Sci. pmid:12068132
Jung YS et al. Antithrombotic effect of onion in streptozotocin-induced diabetic rat. 2002 Prostaglandins Leukot. Essent. Fatty Acids pmid:12054917
van Kraaij DJ et al. A comparison of the effects of nabumetone vs meloxicam on serum thromboxane B2 and platelet function in healthy volunteers. 2002 Br J Clin Pharmacol pmid:12047490
Appleyard CB et al. Temporal changes in colonic vascular architecture and inflammatory mediator levels in animal models of colitis. 2002 Dig. Dis. Sci. pmid:12353846
Saldeen P et al. Structural, functional and circulatory placental changes associated with impaired glucose metabolism. 2002 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:12381475
Dionne RA et al. Analgesia and COX-2 inhibition. 2001 Nov-Dec Clin. Exp. Rheumatol. pmid:11695255
Resnick DK et al. Regional and temporal changes in prostaglandin E2 and thromboxane B2 concentrations after spinal cord injury. 2001 Nov-Dec Spine J pmid:14588301
Resnick DK et al. Selective cyclooxygenase 2 inhibition lowers spinal cord prostaglandin concentrations after injury. 2001 Nov-Dec Spine J pmid:14588302
Nakamura H et al. Difference in urinary 11-dehydro TXB2 and LTE4 excretion in patients with rheumatoid arthritis. 2001 Nov-Dec Prostaglandins Leukot. Essent. Fatty Acids pmid:11993724
Rebrov BA [Role of thromboxane A2 (B2) in the pathogenesis of stress proteinuria in healthy persons]. 2001 Mar-Apr Urologiia pmid:11490711
Minuz P et al. NCX4016 (NO-aspirin) inhibits thromboxane biosynthesis and tissue factor expression and activity in human monocytes. 2001 Jul-Aug Med. Sci. Monit. pmid:11433179
Clayton HA et al. A coculture model of intrahepatic islet transplantation: activation of Kupffer cells by islets and acinar tissue. 2001 Jan-Feb Cell Transplant pmid:11294466
Uchiyama M et al. Comparison between nonpulsatile and pulsatile machine perfusion preservation in liver transplantation from non-heart-beating donors. 2001 Feb-Mar Transplant. Proc. pmid:11267136
Oikawa K et al. Elimination of Kupffer cells suppresses activation of nuclear factor kappa B and production of cytokines and eicosanoids in non-heart-beating donors. 2001 Feb-Mar Transplant. Proc. pmid:11267090
Okita M et al. Effect of arachidonic acid-rich oil on lipids and arachidonate metabolites in ethanol- treated rats. 2001 Apr-May Prostaglandins Leukot. Essent. Fatty Acids pmid:11418023
Karamouzis M et al. The response of muscle interstitial prostaglandin E(2)(PGE(2)), prostacyclin I(2)(PGI(2)) and thromboxane A(2)(TXA(2)) levels during incremental dynamic exercise in humans determined by in vivo microdialysis. 2001 Apr-May Prostaglandins Leukot. Essent. Fatty Acids pmid:11418021
Li G et al. Cardiac ischemic preconditioning improves lung preservation in valve replacement operations. 2001 Ann. Thorac. Surg. pmid:11235719
Agnoli GC et al. Volume-induced natriuresis in healthy women: renal metabolism of prostacyclin and thromboxane, and physiological role of prostanoids. 2001 Prostaglandins Leukot. Essent. Fatty Acids pmid:11237476
Liu ZQ et al. [Effect of Astragalus injection on platelet function and plasma endothelin in patients with early stage diabetic nephropathy]. 2001 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:12577356
Qureshi AA et al. Novel tocotrienols of rice bran suppress cholesterogenesis in hereditary hypercholesterolemic swine. 2001 J. Nutr. pmid:11160537
Lin CL et al. [Therapeutic mechanism of combination therapy of ligustrazine and nitrendipine in treating patients with chronic obstructive pulmonary disease]. 2001 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:12577373
Riendeau D et al. Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. 2001 J. Pharmacol. Exp. Ther. pmid:11160644
Al-Qattan KK et al. Thromboxane-B2, prostaglandin-E2 and hypertension in the rat 2-kidney 1-clip model: a possible mechanism of the garlic induced hypotension. 2001 Prostaglandins Leukot. Essent. Fatty Acids pmid:11161580
Sunose Y et al. Effects of FK3311 on pulmonary ischemia-reperfusion injury in a canine model. 2001 J. Surg. Res. pmid:11162041
Cyrus T et al. Lipid peroxidation and platelet activation in murine atherosclerosis. 2001 Circulation pmid:11602498
Grace RF et al. Effects of diclofenac in the rat tail ischaemia--reperfusion injury model of acute hyperalgesia. 2001 Pain pmid:11166467
Watanabe T et al. Enhanced platelet sensitivity to prostacyclin in patients in an active stage of Takayasu arteritis. 2001 Thromb. Res. pmid:11672751
Haastrup A et al. Lipids stimulate the production of 6-keto-prostaglandin f(1alpha) in human dorsal hand veins. 2001 Hypertension pmid:11641299
Ziegler BK et al. Incomplete thromboxane inhibition with 100 mg of intravenous acetylsalicylic acid in patients with acute ST elevation myocardial infarction: a placebo-controlled pilot trial. 2001 Thromb. Res. pmid:11672759
Nüsing RM et al. Pathogenetic role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome: therapeutic use of the cyclooxygenase-2 inhibitor nimesulide. 2001 Clin. Pharmacol. Ther. pmid:11673754
Vagnoni KE et al. The influence of the phase of the estrous cycle on sheep endometrial tissue response to lipopolysaccharide. 2001 J. Anim. Sci. pmid:11219456
Iuliano L et al. Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA. 2001 J. Am. Coll. Cardiol. pmid:11153776
Van Solingen RM et al. Comparison of the effects of ketoprofen on platelet function in the presence and absence of aspirin. 2001 Am. J. Med. pmid:11566459
Ploner F et al. Effects of combined selective iNOS inhibition and peroxynitrite blockade during endotoxemia in pigs. 2001 Shock pmid:11508865
Diebolt M et al. Wine polyphenols decrease blood pressure, improve NO vasodilatation, and induce gene expression. 2001 Hypertension pmid:11509469
Tomida T et al. Altered expression of prostacyclin synthase in a subset of the thick ascending limb cells and mesangial cells in 5/6-nephrectomized rats. 2001 Hypertens. Res. pmid:11510754
Valeri CR et al. Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss. 2001 Transfusion pmid:11493727
Ogata K et al. Attenuation of ischemia and reperfusion injury of canine livers by inhibition of type II phospholipase A2 with LY329722. 2001 Transplantation pmid:11374398
Coelho-Filho OR et al. Pravastatin reduces myocardial lesions induced by acute inhibition of nitric oxide biosynthesis in normocholesterolemic rats. 2001 Int. J. Cardiol. pmid:11461744
Wojakowski W and Gmiński J Plasma levels of von willebrand factor, endothelin-1, prostacyclin and thromboxane in children from families with high risk of premature coronary artery disease. 2001 Scand. J. Clin. Lab. Invest. pmid:11465346
Rosón MI et al. Serotonin hypersensitivity in aorta of two kidney-two clip hypertensive rats: calcium contribution and prostanoids-nitric oxide interactions. 2001 Arch. Physiol. Biochem. pmid:11471069
Catella-Lawson F et al. Oral glycoprotein IIb/IIIa antagonism in patients with coronary artery disease. 2001 Am. J. Cardiol. pmid:11472700
Takeyoshi I et al. The effect of a selective cyclooxygenase-2 inhibitor in extended liver resection with ischemia in dogs. 2001 J. Surg. Res. pmid:11516201
Guyton K et al. Differential effects of 15-deoxy-delta(12,14)-prostaglandin J2 and a peroxisome proliferator-activated receptor gamma agonist on macrophage activation. 2001 J. Leukoc. Biol. pmid:11310850
Muramatsu H et al. [Correlation between the clinical effects of Seratrodast and the level of 11-dehydrothromboxane B2 in urine/sputum in bronchial asthma patients]. 2001 Arerugi pmid:11517517
Calzada C et al. 12(S)-Hydroperoxy-eicosatetraenoic acid increases arachidonic acid availability in collagen-primed platelets. 2001 J. Lipid Res. pmid:11518767
Fritsma GA et al. Monitoring the antiplatelet action of aspirin. 2001 JAAPA pmid:11523339
Zoja C et al. Mycophenolate mofetil combined with a cyclooxygenase-2 inhibitor ameliorates murine lupus nephritis. 2001 Kidney Int. pmid:11473648
Goulet JL et al. Deficiency of 5-lipoxygenase accelerates renal allograft rejection in mice. 2001 J. Immunol. pmid:11714834
Cracowski JL et al. Enhanced in vivo lipid peroxidation in scleroderma spectrum disorders. 2001 Arthritis Rheum. pmid:11352247
Kijima Y et al. Transcardiac 8-iso-prostaglandin F(2 alpha)generation from acute myocardial infarction heart: insight into abrupt reperfusion and oxidant stress. 2001 Prostaglandins Leukot. Essent. Fatty Acids pmid:11334551
Ochi T and Goto T Anti-inflammatory activity of a novel selective cyclooxygenase-2 inhibitor, FR140423, on type II collagen-induced arthritis in Lewis rats. 2001 Prostaglandins Other Lipid Mediat. pmid:11785783
Gao YJ and Lee RM Hydrogen peroxide induces a greater contraction in mesenteric arteries of spontaneously hypertensive rats through thromboxane A(2) production. 2001 Br. J. Pharmacol. pmid:11739239
Mita H et al. Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma. 2001 Allergy pmid:11703219
Domoki F et al. Cyclooxygenase-2 inhibitor NS398 preserves neuronal function after hypoxia/ischemia in piglets. 2001 Neuroreport pmid:11742239
McConnell JP et al. Urinary 11-dehydro-thromboxane B(2) and coagulation activation markers measured within 24 h of human acute ischemic stroke. 2001 Neurosci. Lett. pmid:11684346
Wan Y et al. Effects of cocoa powder and dark chocolate on LDL oxidative susceptibility and prostaglandin concentrations in humans. 2001 Am. J. Clin. Nutr. pmid:11684527
Wang ZY et al. Comparative study of platelet activation markers in diabetes mellitus patients complicated by cerebrovascular disease. 2001 Blood Coagul. Fibrinolysis pmid:11685040
Wang WJ and Huang TF A novel tetrameric venom protein, agglucetin from Agkistrodon acutus, acts as a glycoprotein Ib agonist. 2001 Thromb. Haemost. pmid:11686327
Sunose Y et al. Effect of a cyclooxygenase-2 inhibitor, FK3311, in a canine lung transplantation model. 2001 Ann. Thorac. Surg. pmid:11603431
Minuz P et al. NCX4016 (NO-Aspirin) has multiple inhibitory effects in LPS-stimulated human monocytes. 2001 Br. J. Pharmacol. pmid:11606332
Seno K et al. Pyrrolidine inhibitors of human cytosolic phospholipase A2. Part 2: synthesis of potent and crystallized 4-triphenylmethylthio derivative 'pyrrophenone'. 2001 Bioorg. Med. Chem. Lett. pmid:11229777
Davì G et al. Oxidative stress and platelet activation in homozygous homocystinuria. 2001 Circulation pmid:11535567
Wight NJ et al. Rofecoxib, a COX-2 inhibitor, does not inhibit human gastric mucosal prostaglandin production. 2001 Gastroenterology pmid:11231941
Broulík PD et al. Impact of antihypertensive therapy on the skeleton: effects of enalapril and AT1 receptor antagonist losartan in female rats. 2001 Physiol Res pmid:11551140
Franconi F et al. Effect of gamma-hydroxybutyric acid on human platelet aggregation in vitro. 2001 Thromb. Res. pmid:11369419
Praticò D et al. Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice. 2001 Proc. Natl. Acad. Sci. U.S.A. pmid:11248083
Loew D et al. Investigations on the pharmacokinetic properties of Harpagophytum extracts and their effects on eicosanoid biosynthesis in vitro and ex vivo. 2001 Clin. Pharmacol. Ther. pmid:11372004
Yoshinari D et al. Effects of a dual inhibitor of tumor necrosis factor-alpha and interleukin-1 on lipopolysaccharide-induced lung injury in rats: involvement of the p38 mitogen-activated protein kinase pathway. 2001 Crit. Care Med. pmid:11373433
Feldman M et al. Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay. 2001 J. Am. Coll. Cardiol. pmid:11419884
Dowd NP et al. Inhibition of cyclooxygenase-2 aggravates doxorubicin-mediated cardiac injury in vivo. 2001 J. Clin. Invest. pmid:11518732
Dubé JN et al. Characterization of a partial prostaglandin endoperoxide H synthase-1 deficiency in a patient with a bleeding disorder. 2001 Br. J. Haematol. pmid:11442478
Katoh M et al. Inhibitory effects of TA-993 and its metabolite MB3 on platelet activation induced by collagen and U-46619 in human platelets. 2001 Biol. Pharm. Bull. pmid:11379769
Miyake K et al. Effects of olopatadine hydrochloride on the increase of histamine and peptide-leukotrienes concentrations in nasal lavage fluid following the antigen-antibody reaction in actively sensitized guinea pigs. 2001 Jpn. J. Pharmacol. pmid:11388650
Gossmann J et al. Pathophysiology of cyclosporine-induced nephrotoxicity in humans: a role for nitric oxide? 2001 Kidney Blood Press. Res. pmid:11435743
Cantaro S et al. Urinary excretion of vasoactive substances in chronic renal failure. 2001 Clin. Nephrol. pmid:11393385
Kurokawa K et al. Circadian characteristics of urinary leukotriene E(4) in healthy subjects and nocturnal asthmatic patients. 2001 Chest pmid:11742908
Zhang LH et al. Effects of extract F of red-rooted Salvia on mucosal lesions of gastric corpus and antrum induced by hemorrhagic shock-reperfusion in rats. 2001 World J. Gastroenterol. pmid:11819852
Fujimoto Y et al. Tetrahydrobiopterin attenuates modulation of platelet 12-lipoxygenase and cyclooxygenase activities by nitric oxide. 2001 Nitric Oxide pmid:11178940
Beck-Speier I et al. Agglomerates of ultrafine particles of elemental carbon and TiO2 induce generation of lipid mediators in alveolar macrophages. 2001 Environ. Health Perspect. pmid:11544173
Tuppo EE et al. Sign of lipid peroxidation as measured in the urine of patients with probable Alzheimer's disease. 2001 Brain Res. Bull. pmid:11397549
Norio K et al. Eicosanoids and delayed graft function in human renal transplantation. 2001 Transplant. Proc. pmid:11406239
Sontag W Release of mediators by DMSO-differentiated HL-60 cells exposed to electric interferential current and the requirement of biochemical prestimulation. 2001 Int. J. Radiat. Biol. pmid:11403712
Carvalho CR et al. Antigen-induced bronchial hyperreactivity and bronchopulmonary inflammation in rats: effect of TNF receptor binding protein. 2001 Exp. Lung Res. pmid:11258800
Suliman HB et al. Prevention of influenza-induced lung injury in mice overexpressing extracellular superoxide dismutase. 2001 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:11133496